I help B2B technology companies and founders turn market intelligence into commercial traction through GTM strategy, commercialisation, positioning, and India market entry decisions. Nineteen years. Over a hundred clients. The same problem at the centre of every engagement.
Most GTM problems are misdiagnosed before they are ever fixed. Companies adjust messaging when the real issue is ICP. They commission more research when the real issue is how the intelligence is being interpreted. They build a GTM motion without understanding how buyers in their target market actually decide.
The work I do sits at the intersection of market intelligence and commercial judgment. Not analysis for its own sake. Not strategy that lives in a deck. The question I am always answering is: what does this intelligence mean for the commercial decision in front of you, and what needs to change first.
Commercial intelligence that changes what you decide, not just what you know. These are the outcomes that recur across engagements.
Commercial judgment developed through real market exposure is not replicable from training data. Sitting in rooms where the cost of being wrong was real, working directly with CFO and President leadership on decisions with revenue consequences, leading OEM engagement with no precedent and no safety net: that accumulation of pattern recognition is not available in any dataset.
Understanding how buyers in India and emerging markets actually think requires direct commercial situations, not secondary research. Decision hierarchies in Indian enterprise are different. The role of relationships and ecosystem influencers is different. What signals genuine buying intent versus polite engagement that will never convert is different. You learn this by being in the room repeatedly, not by reading about it.
The GLG Expert Council re-empanelment in May 2026, after nine consecutive years from 2013 to 2021, is the clearest external signal available. Global investment funds, private equity firms, and consulting organisations engaged this judgment specifically, year after year. They were not buying a report. They were buying a read on situations that standard research could not give them.
Every credential below represents a context where the intelligence had to be right because real decisions depended on it.
Client names are not disclosed as a standard professional practice. The commercial detail is sufficient to evaluate whether this is the kind of work you need.
The company believed the challenge was identifying where to sell in India. The real challenge was identifying where it could win first.
The product required technical evaluation, demonstration, installation support and ongoing service. This eliminated the most obvious entry options immediately. Large enterprise accounts had established global suppliers and would not risk an unknown vendor. National distributors offered geographic reach but not the technical selling capability needed to influence specification decisions. Without local references or service credibility, every sales conversation would eventually arrive at the same unanswered question: what happens after we buy? The constraint was not product quality. It was commercial credibility.
The market entry was sequenced around a small number of reference deployments rather than the largest available accounts. The primary ICP became mid-sized manufacturing firms in automotive components and precision engineering, combining identifiable production challenges with significantly shorter commercial decision cycles than Tier-1 manufacturers. Geography followed the ICP: Pune was recommended as the beachhead because it combined manufacturing density, a mature partner ecosystem and the highest concentration of qualified buyers. The channel strategy prioritised technically capable value-added resellers over national distributors. The GTM narrative shifted from product specifications to total cost of ownership and after-sales reliability.
The first customer matters more than the hundredth because every subsequent buyer evaluates the evidence created by the first. Market research identifies opportunity; commercial strategy determines where credibility is built first. The fastest route into a new market is rarely the largest segment. It is the segment that generates the reference customers the larger market will trust.
The founder believed the product needed better messaging. The real constraint was that it was being positioned to the wrong buyer entirely.
The business was generating conversations but not buying decisions. Despite technically strong product capability, pipeline conversion remained inconsistent after multiple rounds of messaging refinement. The GTM strategy had been built around industries and personas rather than buying behaviour. Within the same organisation, different stakeholders evaluated the platform through entirely different commercial lenses. Technical teams valued capability. Business units valued productivity. Finance evaluated return on investment. The constraint was not insufficient demand. It was the absence of a clearly defined economic buyer with an urgent, measurable commercial reason to act.
The GTM strategy was rebuilt around buyer diagnosis rather than industry selection. The critical diagnostic question was direct: of all pipeline conversations in the preceding ninety days, how many resulted in a second meeting initiated by the buyer without being chased? Very few. Buyers with genuine commercial urgency return unprompted. The ICP was rebuilt around buying triggers, budget ownership and decision authority. The entry point shifted from innovation and technology heads to Chief Risk Officers, harder initial access but fundamentally different conversion potential because commercial urgency and budget authority sat in the same role. Messaging was rewritten around measurable business outcomes rather than technical features.
Markets do not buy products; specific buyers solve specific commercial problems. The strongest ICP is not the largest addressable market. It is the segment where commercial urgency, budget ownership and implementation readiness align simultaneously. Commercial repositioning frequently creates more growth than additional marketing investment because the right buyer removes friction from the entire sales process.
The company believed it needed more distributors. The real constraint was that its channel lacked the commercial capability to sell.
The product required technical understanding, consultative selling and close engagement with engineering, procurement and operational stakeholders across complex enterprise buying committees. Traditional volume distributors excelled at product fulfilment and geographic coverage. They were not equipped to influence technical buying decisions or build the multi-stakeholder relationships that enterprise specification requires. The commercial bottleneck sat between awareness and adoption. Without technically credible partners capable of creating demand, every qualified opportunity depended on direct manufacturer intervention, a model that cannot scale and one that signals to the market that the channel has no real capability.
The channel strategy shifted from distributor expansion to ecosystem design. Partners were evaluated against technical competence, existing customer relationships and solution-selling capability rather than annual sales volume or territory coverage. The recommended model combined value-added distributors, system integrators, engineering consultants and specialised solution partners capable of influencing enterprise buying committees. For an adjacent US market category under simultaneous evaluation, a structured go-versus-monitor framework was built connecting certification investment cost to realistic addressable market share, a capital allocation decision the CFO could act on rather than a qualitative recommendation to consider.
Channels should be selected for the customers they can influence, not the territories they cover. Commercial ecosystems outperform distribution networks when enterprise buying requires education, technical confidence and long-term trust. The strongest channel strategy is not measured by partner numbers. It is measured by the quality of commercial conversations those partners create.
The company believed the challenge was finding customers for a new AI platform. The real challenge was creating a commercial model that customers could confidently buy.
The technology was ahead of buyer maturity. Enterprise automotive customers were evaluating a platform they had never purchased before. Traditional software buying frameworks did not apply. Neither did conventional services models. Without a clearly defined commercial structure, every customer conversation began with education rather than evaluation. The constraint was not product innovation; the technical capability was demonstrable and differentiated. It was commercial clarity. Until buyers understood how to adopt, deploy and derive value from the platform within existing automotive procurement processes, scaling revenue would remain difficult regardless of technical superiority.
The commercial strategy shifted from selling technology to selling commercially packaged outcomes. Rather than positioning the platform as a general-purpose AI capability, the strategy focused on specific ADAS deployment scenarios where implementation complexity, commercial value and buyer ownership aligned within the automotive ecosystem. Structured commercial pathways were introduced including pilot engagements, phased adoption and outcome-led framing to reduce perceived adoption risk. Formal engagement was initiated with global automotive manufacturers. The narrative was built for how OEMs actually evaluate new technology partnerships, not how a startup assumes they do.
Innovation becomes commercially valuable only when customers understand how to buy it. Commercial models should simplify adoption before attempting to maximise feature breadth. The strongest technology strategy is not the one with the most capabilities. It is the one that creates the least uncertainty for the buyer.
The client believed they needed more market research. The real constraint was the absence of commercial interpretation.
The organisation possessed extensive market information. Industry reports quantified market size. Competitor benchmarking mapped positioning. Customer surveys identified broad buying preferences. What was absent was the analytical layer that converts data into decisions. Traditional research described what was happening. It did not explain why Indian enterprise buyers changed suppliers, how buying committees reached consensus in ways that differ structurally from Western European procurement, which commercial signals genuinely predicted purchasing behaviour, or why a sales motion designed for one market would stall at specific points in another. Strategic planning remained descriptive rather than commercially actionable.
The engagement shifted from market observation to buyer decision mapping. Rather than producing additional research, the work examined commercial triggers, procurement behaviour, stakeholder influence dynamics and enterprise buying patterns specific to the target segment in India. Market intelligence was reorganised around decision-making rather than market segmentation. The output identified who holds technical authority versus commercial authority in Indian enterprise hierarchies, how to distinguish genuine buying intent from culturally polite engagement that will not convert, and which signals consistently preceded purchasing decisions in the sector.
Market intelligence creates value only when it changes commercial decisions. Understanding buyers is more valuable than measuring markets because purchasing behaviour determines revenue outcomes. The strongest growth strategies emerge when market evidence is interpreted through the lens of commercial execution rather than research completeness.
The company believed the fastest path to revenue was acquiring the largest number of customers. The real constraint was building commercial proof before attempting to scale.
The business already possessed valuable commercial assets: existing client relationships across two geographies, five years of proprietary operating data, an internal team of over a hundred recruiters and a physical presence within an ecosystem of more than 500 companies. Yet the original GTM strategy treated the market as though the company were starting from zero. The constraint was not market opportunity; demand was identifiable and the product was differentiated. It was the failure to sequence existing commercial assets before investing in cold acquisition. Without early reference architecture, customer acquisition costs would rise, enterprise sales cycles would lengthen and future expansion would become significantly more expensive.
The commercialisation strategy was rebuilt around asset-led market entry. Mid-market organisations and recently funded Series A and Series B companies were prioritised because successful deployments within those accounts would generate commercial proof, reduce perceived buying risk and accelerate every subsequent sales conversation. Revenue architecture, buyer strategy and execution sequencing were designed around building commercial credibility before pursuing scale. A regulatory compliance deadline was identified as a time-bound buying trigger for the mid-market segment and stress-tested against scenarios where enforcement softened, with the underlying cost-of-manual-compliance argument remaining commercially valid regardless of regulatory timing.
Commercialise through assets you already own before investing in assets you need to acquire. Reference architecture reduces customer acquisition costs more effectively than expanding marketing activity. The first customers should be selected for the commercial credibility they create, not simply the revenue they generate.
The engagement model is not a product catalogue. It is structured around what you are trying to decide and at what stage you need external judgment to come in. Some situations call for a single focused conversation. Others call for sustained involvement across a commercial cycle. The right structure becomes clear in the first conversation.
Every engagement begins with a free 20-minute diagnostic call. No pitch. The purpose is to understand what commercial decision you are carrying and whether the kind of judgment I bring is actually what you need. If it is not, I will tell you that directly.
For sustained engagements, the work is structured as a monthly retainer, scoped and confirmed after the initial conversation. For defined problems, project-based work is scoped separately. The full range of engagement options, including session-based advisory for specific decisions, is available at the link below.
A focused diagnostic to identify where the real commercial gap is: ICP precision, positioning, GTM motion, or India market entry sequencing. Twenty minutes. The outcome is a clear read on what to fix first, whether or not we work together.
Book Free Diagnostic Call →If you have a specific commercial question on India market entry, GTM strategy, or positioning and want to share context before booking a call, send a note here. I will get back within 48 hours.
Share a brief note about what you are working on and I will get back within 48 hours.